Sakar Healthcare Ltd

NSE: SAKAR · Pharmaceuticals & Biotechnology · 8 announcements

Share price: ₹1,135.85
Market cap: ₹2,527 Cr
Revenue (annual): ₹251.7 Cr
Net profit (annual): ₹30.48 Cr
P/E (TTM): 70.0×Sector 50.4×
Promoter holding: 52.52%-0.34% QoQ
FII holding: 12.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Other Announcement 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 Jul 2026 17:10 IST NSE

Earnings CallAlfa Alert

Sakar Healthcare Earnings Call Transcript: Key Takeaways

Sakar Healthcare Q1 FY27 results show strong oncology pivot with 38% YoY revenue growth and 120% profit jump.

Call: Guides 100% growth

Open call summary → Read the story on ALFA News Read the filing ↗

28 Jul 2026 14:01 IST NSE

Earnings Call

Sakar Healthcare Investor Presentation: Key Takeaways

Sakar Healthcare reported strong Q1FY27 consolidated results with 38% Revenue growth and 120% PAT growth, driven by its vertically integrated oncology business and expansion into regulated markets.

Open call summary → Read the filing ↗